Triple M overlap syndrome (TMOS): Evaluating immune checkpoint inhibitor-related overlap syndrome of myocarditis, myositis and myasthenia gravis using an international pharmacovigilance database.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Oklahoma Medical Center, OU Health Stephenson Cancer Center, University of Oklahoma, Jordan University of Science and Technology, Saudi Food and Drug Authority, Allegheny Health Network, Allegheny General Hospital, Morehouse School of Medicine, Huntsman Cancer Institute, Stanford Cancer Institute, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Vanderbilt University Medical Center, Yale Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399662668